New Edge Advisors, LLC Sab Biotherapeutics Inc Wt Exp Transaction History
New Edge Advisors, LLC
- $18.3 Billion
- Q2 2025
A detailed history of New Edge Advisors, LLC transactions in Sab Biotherapeutics Inc Wt Exp stock. As of the latest transaction made, New Edge Advisors, LLC holds 1,072 shares of SABSW stock, worth $32. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,072
Previous 1,072
-0.0%
Holding current value
$32
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding SABSW
# of Institutions
8Shares Held
802KCall Options Held
62.5KPut Options Held
0-
Lmr Partners LLP London, X0540KShares$16,1870.0% of portfolio
-
Morgan Stanley New York, NY146KShares$4,3930.0% of portfolio
-
Clear Street LLC78.8KShares$2,3640.0% of portfolio
-
Walleye Trading LLC Plymouth, MN31.9KShares$9550.0% of portfolio
-
Wolverine Asset Management LLC4.62KShares$1380.0% of portfolio
About SAB BIOTHERAPEUTICS INC WT EXP
- Ticker SABSW
- Sector Healthcare
- Industry Biotechnology